 I. To estimate the maximum tolerated dose of radiation delivered via 131 I-BC8 antibody iodine I 131 monoclonal antibody BC8 when combined with pre- and post-transplant cyclophosphamide CY, fludarabine phosphate FLU, 2 Gy total-body irradiation TBI, tacrolimus, mycophenolate mofetil MMF, and a haploidentical allogeneic hematopoietic marrow transplant in patients who have advanced acute myeloid leukemia AML, acute lymphoblastic leukemia ALL, or high risk myelodysplastic syndromes MDS. 